Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
Male
0301 basic medicine
Lung Neoplasms
Science
Adenocarcinoma of Lung
Cell Separation
Mice, SCID
Adenocarcinoma
Immunophenotyping
Mice
03 medical and health sciences
Biomarkers, Tumor
Cell Adhesion
Animals
Humans
Aged
Aged, 80 and over
Q
R
Computational Biology
Aldehyde Dehydrogenase
Immunohistochemistry
Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Animals; Biomarkers, Tumor; Cell Adhesion; Cell Separation; Computational Biology; Female; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Immunohistochemistry; Immunophenotyping; Lung Neoplasms; Male; Mice; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Pleural Effusion, Malignant; Reverse Transcriptase Polymerase Chain Reaction; Spheroids, Cellular; Tumor Cells, Cultured; Xenograft Model Antitumor Assays
3. Good health
Gene Expression Regulation, Neoplastic
Medicine
Female
Research Article
Genes, Neoplasm
DOI:
10.1371/journal.pone.0021320
Publication Date:
2011-07-18T20:50:40Z
AUTHORS (23)
ABSTRACT
Malignant pleural effusions (MPEs) could represent an excellent source to culture a wide variety of cancer cells from different donors. In this study, we set up conditions for deriving MPEs several patients affected by the most frequent form lung cancer, namely subset non small cell cancers (NSCLC) classified as Lung Adenocarcinomas (AdenoCa) which account approximately 40% cases. AdenoCa malignant gave rise in vitro cultures both adherent and/or spheroid almost all cases analyzed. We characterized greater detail two samples showed efficient propagation vitro. these also compared gene profiles vs and identified differentially expressed genes. Finally achieved tumor engraftment recipient NOD/SCID mice, upon inoculation number cells, thus suggesting indirectly presence initiating cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (57)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....